Pharma · Private company
Janssen, LP
Track this companyFree. Adds Janssen, LP to your Dealase workspace and tells you when its record changes.
Clinical trials258 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials25
- Computerized Decision Support to Prevent Stroke in Atrial FibrillationNA · NOT_YET_RECRUITING · started Dec 30, 2026ClinicalTrials.gov NCT06355986 · fetched Nov 12, 2026
- Daratumumab for Polyneuropathy Associated With MGUSPHASE2 · WITHDRAWN · started Sep 26, 2025ClinicalTrials.gov NCT06046287 · fetched Nov 12, 2026
- Novel Treatments in Improving Renal Outcomes in Light Chain Cast NephropathyCOMPLETED · started Jun 1, 2024ClinicalTrials.gov NCT06483139 · fetched Nov 12, 2026
- Anti-CD38 Antibody With KRAS Vaccine and Anti-PD-1 Antibody in Subjects With Pancreatic Ductal Adenocarcinoma and Refractory Non-Small Cell Lung CancerPHASE2 · ACTIVE_NOT_RECRUITING · started Jan 31, 2024ClinicalTrials.gov NCT06015724 · fetched Nov 12, 2026
- Sustained Humoral and Cell-Mediated Immunogenicity of COVID-19 Vaccines in Patients With Inflammatory Bowel DiseaseUNKNOWN · started Jul 5, 2023ClinicalTrials.gov NCT05014555 · fetched Nov 12, 2026
- Endothelin-1 and Cardiac Allograft Vasculopathy (CAV)PHASE4 · COMPLETED · started May 19, 2022ClinicalTrials.gov NCT05373108 · fetched Nov 12, 2026
- A Study of Daratumumab With Pomalidomide, Dexamethasone, and All-Transretinoic Acid in Patients With Multiple MyelomaPHASE2 · TERMINATED · started May 2, 2022ClinicalTrials.gov NCT04700176 · fetched Nov 12, 2026
- Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate CancerPHASE2 · RECRUITING · started Sep 21, 2021ClinicalTrials.gov NCT04812366 · fetched Nov 12, 2026
- Antiandrogen Therapy and SBRT in Treating Patients With Recurrent, Metastatic Prostate CancerPHASE2 · ACTIVE_NOT_RECRUITING · started Mar 17, 2021ClinicalTrials.gov NCT03902951 · fetched Nov 12, 2026
- A Study to Evaluate Efficacy and Safety of Cabotegravir (CAB) Long Acting (LA) Plus (+) Rilpivirine (RPV) LA Versus BIKTARVY® (BIK) in Participants With Human Immunodeficiency Virus (HIV)-1 Who Are Virologically SuppressedPHASE3 · COMPLETED · started Nov 9, 2020ClinicalTrials.gov NCT04542070 · fetched Nov 12, 2026
- Niraparib Before Surgery in Treating Patients With High Risk Localized Prostate Cancer and DNA Damage Response DefectsPHASE2 · TERMINATED · started Feb 25, 2020ClinicalTrials.gov NCT04030559 · fetched Nov 12, 2026
- Pilot Trial of Ustekinumab for Primary Sjögren's SyndromePHASE1 · COMPLETED · started Jan 15, 2020ClinicalTrials.gov NCT04093531 · fetched Nov 12, 2026
- Study of Daratumumab Combined With Carfilzomib, Lenalidomide and Dexamethasone for Newly Diagnosed Multiple MyelomaPHASE2 · ACTIVE_NOT_RECRUITING · started Jan 10, 2020ClinicalTrials.gov NCT04113018 · fetched Nov 12, 2026
- Study of SubQ Dara With Dose-Attenuated Bortezomib, Lenalidomide, Dexamethasone in Elderly NDMMPHASE2 · COMPLETED · started Oct 24, 2019ClinicalTrials.gov NCT04052880 · fetched Nov 12, 2026
- Daratumumab, Ixazomib, & Dexamethasone or Daratumumab, Bortezomib, & Dexamethasone in Patients With Newly Diagnosed Multiple MyelomaPHASE2 · UNKNOWN · started Jul 3, 2019ClinicalTrials.gov NCT03942224 · fetched Nov 12, 2026
- Daratumumab, Ixazomib, Pomalidomide, and Dexamethasone as Salvage Therapy in Relapsed/Refractory Multiple MyelomaPHASE2 · TERMINATED · started Oct 17, 2018ClinicalTrials.gov NCT03590652 · fetched Nov 12, 2026
- Phase 2b, Open-label, Multicenter, Rollover Study to Assess Antiviral Activity and Safety of Long-acting (LA) Cabotegravir (CAB) Plus LA Rilpivirine (RPV), Administered Every 2 Months (Q2M), in Human Immunodeficiency Virus (HIV)-Positive Participants From the LATTE StudyPHASE2 · COMPLETED · started Sep 24, 2018ClinicalTrials.gov NCT03639311 · fetched Nov 12, 2026
- Natural History Study of Patients With X-linked Retinal Dystrophy Associated With Mutations in Retinitis Pigmentosa GTPase Regulator (RPGR)COMPLETED · started Dec 19, 2017ClinicalTrials.gov NCT03349242 · fetched Nov 12, 2026
- Phase IB Trial of Radium-223 and Niraparib in Patients With Castrate Resistant Prostate Cancer (NiraRad)PHASE1 · COMPLETED · started Sep 22, 2017ClinicalTrials.gov NCT03076203 · fetched Nov 12, 2026
- 2015-12: A Study Exploring the Use of Early and Late Consolidation/Maintenance TherapyPHASE2 · ACTIVE_NOT_RECRUITING · started Jul 1, 2017ClinicalTrials.gov NCT03004287 · fetched Nov 12, 2026
- TLR9 Agonist SD-101, Ibrutinib, and Radiation Therapy in Treating Patients With Relapsed or Refractory Grade 1-3A Follicular LymphomaPHASE1_PHASE2 · COMPLETED · started Nov 7, 2016ClinicalTrials.gov NCT02927964 · fetched Nov 12, 2026
- Ibrutinib in Combination With Rituximab and Lenalidomide in Treating Patients With Previously Untreated, Stage II-IV Follicular Lymphoma or Marginal Zone LymphomaPHASE2 · COMPLETED · started Apr 11, 2016ClinicalTrials.gov NCT02532257 · fetched Nov 12, 2026
- Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation. Master Protocol DIAN-TU-001PHASE2_PHASE3 · ACTIVE_NOT_RECRUITING · started Dec 1, 2012ClinicalTrials.gov NCT01760005 · fetched Nov 12, 2026
- An Investigational Immuno-Therapy Study to Determine the Safety and Effectiveness of Nivolumab and Daratumumab in Patients With Multiple MyelomaPHASE1_PHASE2 · COMPLETED · started Aug 2, 2012ClinicalTrials.gov NCT01592370 · fetched Nov 12, 2026
- Brigham and Women's Rheumatoid Arthritis Sequential StudyACTIVE_NOT_RECRUITING · started Mar 1, 2003ClinicalTrials.gov NCT01793103 · fetched Nov 12, 2026